非小细胞肺癌术前CT放射学分析和液体活检:一种探索性经验。

IF 2.3 3区 医学 Q3 ONCOLOGY
Maria Paola Belfiore, Mario Sansone, Giovanni Ciani, Vittorio Patanè, Carlotta Genco, Roberta Grassi, Giovanni Savarese, Marco Montella, Riccardo Monti, Salvatore Cappabianca, Alfonso Reginelli
{"title":"非小细胞肺癌术前CT放射学分析和液体活检:一种探索性经验。","authors":"Maria Paola Belfiore, Mario Sansone, Giovanni Ciani, Vittorio Patanè, Carlotta Genco, Roberta Grassi, Giovanni Savarese, Marco Montella, Riccardo Monti, Salvatore Cappabianca, Alfonso Reginelli","doi":"10.1111/1759-7714.70115","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nonsmall cell lung cancer (NSCLC) remains a significant global health burden, necessitating advancements in diagnostic and prognostic strategies. Liquid biopsy and radiomics offer promising avenues for enhancing preoperative assessment and treatment planning in NSCLC.</p><p><strong>Methods: </strong>This prospective study enrolled 60 NSCLC patients who underwent both computed tomography (CT)-guided biopsy and liquid biopsy. Radiomic features were extracted from CT images, and circulating tumor DNA (ctDNA) was sequenced to identify genetic mutations. Machine learning algorithms were employed to assess the association between radiomic features and gene mutations.</p><p><strong>Results: </strong>Among 57 patients with available data, associations between radiomic features and gene pairs mutation obtained from liquid biopsy exhibited moderate accuracy (approximately 0.60), with texture features demonstrating higher importance. However, when predicting the combined mutation status of gene pairs (e.g., EGFR and ROS1), the classification task involved three classes and yielded substantially lower accuracy (approximately 0.30), likely due to class imbalance and increased complexity.</p><p><strong>Discussion: </strong>Our findings demonstrate a moderate association between radiomic features and single gene mutations detected through liquid biopsy in NSCLC patients, with classification accuracies reaching approximately 0.60. In contrast, classification performance significantly declined (to ~0.30) when gene mutation pairs were used as targets, likely due to increased complexity and class imbalance. Notably, second-order texture features showed the highest importance in the models. These preliminary results suggest that radiomics may capture aspects of tumor biology reflected in liquid biopsy, warranting further validation in larger, well-balanced cohorts.</p><p><strong>Conclusion: </strong>The integration of liquid biopsy and radiomics holds promise for enhancing preoperative assessment and personalized treatment strategies in NSCLC. Further research on larger cohorts is warranted to validate the findings and translate them into clinical practice.</p><p><strong>Trial registration: </strong>University of Campania Trial Board UC20201112-24997.</p>","PeriodicalId":23338,"journal":{"name":"Thoracic Cancer","volume":"16 13","pages":"e70115"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224037/pdf/","citationCount":"0","resultStr":"{\"title\":\"Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC: An Explorative Experience.\",\"authors\":\"Maria Paola Belfiore, Mario Sansone, Giovanni Ciani, Vittorio Patanè, Carlotta Genco, Roberta Grassi, Giovanni Savarese, Marco Montella, Riccardo Monti, Salvatore Cappabianca, Alfonso Reginelli\",\"doi\":\"10.1111/1759-7714.70115\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Nonsmall cell lung cancer (NSCLC) remains a significant global health burden, necessitating advancements in diagnostic and prognostic strategies. Liquid biopsy and radiomics offer promising avenues for enhancing preoperative assessment and treatment planning in NSCLC.</p><p><strong>Methods: </strong>This prospective study enrolled 60 NSCLC patients who underwent both computed tomography (CT)-guided biopsy and liquid biopsy. Radiomic features were extracted from CT images, and circulating tumor DNA (ctDNA) was sequenced to identify genetic mutations. Machine learning algorithms were employed to assess the association between radiomic features and gene mutations.</p><p><strong>Results: </strong>Among 57 patients with available data, associations between radiomic features and gene pairs mutation obtained from liquid biopsy exhibited moderate accuracy (approximately 0.60), with texture features demonstrating higher importance. However, when predicting the combined mutation status of gene pairs (e.g., EGFR and ROS1), the classification task involved three classes and yielded substantially lower accuracy (approximately 0.30), likely due to class imbalance and increased complexity.</p><p><strong>Discussion: </strong>Our findings demonstrate a moderate association between radiomic features and single gene mutations detected through liquid biopsy in NSCLC patients, with classification accuracies reaching approximately 0.60. In contrast, classification performance significantly declined (to ~0.30) when gene mutation pairs were used as targets, likely due to increased complexity and class imbalance. Notably, second-order texture features showed the highest importance in the models. These preliminary results suggest that radiomics may capture aspects of tumor biology reflected in liquid biopsy, warranting further validation in larger, well-balanced cohorts.</p><p><strong>Conclusion: </strong>The integration of liquid biopsy and radiomics holds promise for enhancing preoperative assessment and personalized treatment strategies in NSCLC. Further research on larger cohorts is warranted to validate the findings and translate them into clinical practice.</p><p><strong>Trial registration: </strong>University of Campania Trial Board UC20201112-24997.</p>\",\"PeriodicalId\":23338,\"journal\":{\"name\":\"Thoracic Cancer\",\"volume\":\"16 13\",\"pages\":\"e70115\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224037/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thoracic Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/1759-7714.70115\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thoracic Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1759-7714.70115","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:非小细胞肺癌(NSCLC)仍然是一个重要的全球健康负担,需要在诊断和预后策略方面取得进展。液体活检和放射组学为加强非小细胞肺癌的术前评估和治疗计划提供了有希望的途径。方法:这项前瞻性研究招募了60名非小细胞肺癌患者,他们接受了计算机断层扫描(CT)引导下的活检和液体活检。从CT图像中提取放射学特征,并对循环肿瘤DNA (ctDNA)进行测序以确定基因突变。使用机器学习算法来评估放射学特征与基因突变之间的关系。结果:在57例有数据的患者中,从液体活检中获得的放射学特征和基因对突变之间的关联显示出中等的准确性(约0.60),纹理特征显示出更高的重要性。然而,当预测基因对的组合突变状态(例如,EGFR和ROS1)时,分类任务涉及三个类别,并且准确度大大降低(约0.30),可能是由于类别不平衡和复杂性增加。讨论:我们的研究结果表明,通过NSCLC患者液体活检检测到的放射学特征与单基因突变之间存在中度关联,分类准确率约为0.60。相比之下,当使用基因突变对作为目标时,分类性能显著下降(至~0.30),可能是由于复杂性增加和类别不平衡。值得注意的是,二阶纹理特征在模型中表现出最高的重要性。这些初步结果表明放射组学可以捕获液体活检中反映的肿瘤生物学方面,需要在更大、平衡的队列中进一步验证。结论:液体活检和放射组学的结合有望加强非小细胞肺癌的术前评估和个性化治疗策略。需要对更大的队列进行进一步的研究,以验证这些发现并将其转化为临床实践。试验注册:坎帕尼亚大学试验委员会UC20201112-24997。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC: An Explorative Experience.

Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC: An Explorative Experience.

Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC: An Explorative Experience.

Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC: An Explorative Experience.

Background: Nonsmall cell lung cancer (NSCLC) remains a significant global health burden, necessitating advancements in diagnostic and prognostic strategies. Liquid biopsy and radiomics offer promising avenues for enhancing preoperative assessment and treatment planning in NSCLC.

Methods: This prospective study enrolled 60 NSCLC patients who underwent both computed tomography (CT)-guided biopsy and liquid biopsy. Radiomic features were extracted from CT images, and circulating tumor DNA (ctDNA) was sequenced to identify genetic mutations. Machine learning algorithms were employed to assess the association between radiomic features and gene mutations.

Results: Among 57 patients with available data, associations between radiomic features and gene pairs mutation obtained from liquid biopsy exhibited moderate accuracy (approximately 0.60), with texture features demonstrating higher importance. However, when predicting the combined mutation status of gene pairs (e.g., EGFR and ROS1), the classification task involved three classes and yielded substantially lower accuracy (approximately 0.30), likely due to class imbalance and increased complexity.

Discussion: Our findings demonstrate a moderate association between radiomic features and single gene mutations detected through liquid biopsy in NSCLC patients, with classification accuracies reaching approximately 0.60. In contrast, classification performance significantly declined (to ~0.30) when gene mutation pairs were used as targets, likely due to increased complexity and class imbalance. Notably, second-order texture features showed the highest importance in the models. These preliminary results suggest that radiomics may capture aspects of tumor biology reflected in liquid biopsy, warranting further validation in larger, well-balanced cohorts.

Conclusion: The integration of liquid biopsy and radiomics holds promise for enhancing preoperative assessment and personalized treatment strategies in NSCLC. Further research on larger cohorts is warranted to validate the findings and translate them into clinical practice.

Trial registration: University of Campania Trial Board UC20201112-24997.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Thoracic Cancer
Thoracic Cancer ONCOLOGY-RESPIRATORY SYSTEM
CiteScore
5.20
自引率
3.40%
发文量
439
审稿时长
2 months
期刊介绍: Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society. The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信